148 related articles for article (PubMed ID: 32674607)
1. Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C.
Mazzini C; Pieretti G; Vicini G; Nicolosi C; Virgili G; Giansanti F
Eur J Ophthalmol; 2021 Nov; 31(6):NP71-NP74. PubMed ID: 32674607
[TBL] [Abstract][Full Text] [Related]
2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
3. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
Finger PT; Czechonska G; Liarikos S
Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
[TBL] [Abstract][Full Text] [Related]
4. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
Kurli M; Finger PT
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
[TBL] [Abstract][Full Text] [Related]
5. Hughes technique, amniotic membrane allograft, and topical chemotherapy in conjunctival melanoma with eyelid involvement.
Becerra EM; Blanco G; Saornil MA; del C Méndez M; Bianciotto CG
Ophthalmic Plast Reconstr Surg; 2005 May; 21(3):238-40. PubMed ID: 15942504
[TBL] [Abstract][Full Text] [Related]
6. Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy.
Shields CL; Shields JA; Armstrong T
Am J Ophthalmol; 2001 Oct; 132(4):576-8. PubMed ID: 11589886
[TBL] [Abstract][Full Text] [Related]
7. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia.
Paridaens D; Beekhuis H; van Den Bosch W; Remeyer L; Melles G
Br J Ophthalmol; 2001 Jun; 85(6):658-61. PubMed ID: 11371482
[TBL] [Abstract][Full Text] [Related]
8. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
Werschnik C; Lommatzsch PK
Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
[TBL] [Abstract][Full Text] [Related]
9. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
Chalasani R; Giblin M; Conway RM
Clin Exp Ophthalmol; 2006; 34(7):708-14. PubMed ID: 16970772
[TBL] [Abstract][Full Text] [Related]
10. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
Sacu S; Ségur-Eltz N; Horvat R; Lukas JR; Zehetmayer M
Am J Ophthalmol; 2003 Aug; 136(2):375-7. PubMed ID: 12888073
[TBL] [Abstract][Full Text] [Related]
11. Surgical excision, cryotherapy, autolimbal transplantation and mitomycin-C in treatment of conjunctival-corneal intraepithelial neoplasia.
Doganay S; Er H; Tasar A; Gürses I
Int Ophthalmol; 2005; 26(1-2):53-7. PubMed ID: 16779567
[TBL] [Abstract][Full Text] [Related]
12. Topical mitomycin C in the treatment of pigmented conjunctival lesions.
Rodríguez-Ares T; Touriño R; De Rojas V; Becerra E; Capeans C
Cornea; 2003 Mar; 22(2):114-7. PubMed ID: 12605043
[TBL] [Abstract][Full Text] [Related]
13. Primary acquired melanosis with atypia treated with mitomycin C.
Anandajeya WV; Corrêa ZM; Augsburger JJ
Int Ophthalmol; 2009 Aug; 29(4):285-8. PubMed ID: 18438612
[TBL] [Abstract][Full Text] [Related]
14. Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
Chaparro Tapias TA; Díaz Díaz AL; Secondi R; Coy Villamil H; Sánchez España JC
Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):558-561. PubMed ID: 30072188
[TBL] [Abstract][Full Text] [Related]
15. Corneal melanosis successfully treated using topical mitomycin-C and alcohol corneal epitheliectomy: a 3-year follow-up case report.
Balcı M; Yağcı R; Güler E; Haltaş H; Duman R; Hepşen İF
Arq Bras Oftalmol; 2015; 78(4):255-6. PubMed ID: 26375344
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I.
Stacy RC; Kenyon KR; Jakobiec FA; Colby KA
Cornea; 2010 Feb; 29(2):232-4. PubMed ID: 20023582
[TBL] [Abstract][Full Text] [Related]
17. [Topical Mitomycin C as a therapy of conjunctival tumours].
Schallenberg M; Niederdräing N; Steuhl KP; Meller D
Ophthalmologe; 2008 Aug; 105(8):777-84. PubMed ID: 18618124
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
Colby KA; Nagel DS
Cornea; 2005 Apr; 24(3):352-5. PubMed ID: 15778614
[TBL] [Abstract][Full Text] [Related]
19. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
Cid-Bertomeu P; Huerva V
Surv Ophthalmol; 2022; 67(5):1391-1404. PubMed ID: 35278438
[TBL] [Abstract][Full Text] [Related]
20. The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.
Yuen HK; Yeung EF; Chan NR; Chi SC; Lam DS
Cornea; 2002 Nov; 21(8):838-9. PubMed ID: 12410049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
